rhuFVIIa in Post-partum Hemorrhage
Recombinant Human Activated Factor VII as Salvage Therapy in Women With Severe Postpartum Hemorrhage
Sponsor: Assistance Publique - Hôpitaux de Paris
Listed as NCT00370877, this PHASE4 trial focuses on Postpartum Hemorrhage and remains completed. Sponsored by Assistance Publique - Hôpitaux de Paris, it has been updated 6 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Apr 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
- Centre Hospitalier Universitaire de Nice
- Centre Hospitalier Universitaire de Nīmes
- University Hospital, Geneva
- University Hospital, Lille
- University Hospital, Montpellier
For direct contact, visit the study record on ClinicalTrials.gov .